| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/12/2006 | EP1317272B1 Composition for improving the cell protection comprising a lipophilic antioxidant an a hydrophilic antioxidant |
| 04/12/2006 | EP1297116B1 Method for isolating and purifying a protein |
| 04/12/2006 | EP1270017B1 Radiolabeled pyrimidine nucleoside for the diagnosis of tissue-reproductive activity |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | EP1194156B1 Dietary supplement for treating malignancies and viral infections and improving immune function |
| 04/12/2006 | EP1144435B1 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | EP1087981B1 Prenyl transferase inhibitors |
| 04/12/2006 | EP1054887B1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists |
| 04/12/2006 | EP0843549B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 04/12/2006 | CN1759123A Uses of IL-23 agonists and antagonists; related reagents |
| 04/12/2006 | CN1759118A Diazepinoindole derivatives as kinase inhibitors |
| 04/12/2006 | CN1758923A Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof |
| 04/12/2006 | CN1758918A Use of 5-substituted nucleosides for reinforcing the apoptotic effect of cytostatic drugs |
| 04/12/2006 | CN1758910A Use of isoquinoline derivatives for treating cancer and MAP kinase related diseases |
| 04/12/2006 | CN1758909A Substituted piperidines as novel MDM2-p53 inhibitors |
| 04/12/2006 | CN1758908A Treatment of proliferative diseases with epothilone derivatives and radiation |
| 04/12/2006 | CN1758905A Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 04/12/2006 | CN1757738A Bitarget fibroblast growth factor acceptor and transgene carrier of integrated element |
| 04/12/2006 | CN1757736A Construction expression of fusion gene carrier and its application |
| 04/12/2006 | CN1757411A Traditional Chinese medicine for treating esophague cancer |
| 04/12/2006 | CN1757409A Recipe of Wanshou capsule, and health-care function |
| 04/12/2006 | CN1757408A Green tea medicine for treating and preventing cnacer and tumor, its prepn. method and application |
| 04/12/2006 | CN1757399A 'Wu-gu-teng' stem disperser, and its prepn. method |
| 04/12/2006 | CN1250732C 病毒株 Strains |
| 04/12/2006 | CN1250731C Packaging of positive-strand RNA virus replicon particles |
| 04/12/2006 | CN1250717C Human Enzymes of metalloprotease family |
| 04/12/2006 | CN1250711C Purging of cells using viruses |
| 04/12/2006 | CN1250707C High-yield bacterial strain C-1027-20 for preparing Lidamycin as antineoplastic antibiotic |
| 04/12/2006 | CN1250571C Specific binding molecules for scintigraphy, conjugates containing them and uses |
| 04/12/2006 | CN1250560C Preparation method and application of harmel seed alkaloid |
| 04/12/2006 | CN1250559C Process for preparing amine platinum complexes |
| 04/12/2006 | CN1250548C Novel adenine derivatives |
| 04/12/2006 | CN1250542C 2-(1H-indol-3-yl)-2-oxo-acetamides with antitumor activity |
| 04/12/2006 | CN1250541C Amorphous form of cell cycle inhibitor |
| 04/12/2006 | CN1250529C Rosinyl acridine its producing method and use thereof |
| 04/12/2006 | CN1250526C Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 04/12/2006 | CN1250299C Implant with cavities containing therapeutic agents |
| 04/12/2006 | CN1250294C Photosensitive and method for production thereof |
| 04/12/2006 | CN1250293C Drug composites |
| 04/12/2006 | CN1250288C Beta glycan as an inhibin receptor and uses thereof |
| 04/12/2006 | CN1250285C Cellular vesicle called 'exosome', prepn. and use thereof in immune stimulation |
| 04/12/2006 | CN1250281C Method for treating endothelium wound |
| 04/12/2006 | CN1250279C Liposome targeting of matrix metalloproteinase inhibitors |
| 04/12/2006 | CN1250275C Traditional Chinese medicine for treating cancer and preparation method thereof |
| 04/12/2006 | CN1250273C Venom capsule for treating brain cancer and preparation method |
| 04/12/2006 | CN1250225C Use of 2alpha-methyl-19-nor-20(s)-1alpha, 25-dihydroxyvitamin d3 to increase bone strength |
| 04/12/2006 | CN1250224C Theobromine with anticancer activity |
| 04/12/2006 | CN1250223C Pyrrolo-triazine and pyrimidine compounds |
| 04/11/2006 | USRE39061 Pharmaceutical formulations comprising labdanes for the treatment of tumors or leukemias |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026488 A hemeoxygenase inhibitory metalloprotoporphyrin derivative, especially Zn-protoporphyrin, conjugated with an amphipathic or water soluble polymer; anticarcinogenic agents with little side effect and excellent tumor accumulation; very potent and efficient; administered by intravenous injection; stability |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026484 For therapy of cancer |
| 04/11/2006 | US7026469 Compositions and methods of double-targeting virus infections and cancer cells |
| 04/11/2006 | US7026462 Regulation of angiogenesis with zinc finger proteins |
| 04/11/2006 | US7026443 Composition including an oligopeptide 13 residues or less in length, which comprises the sequence ATLERTEVY (SEQ ID NO:31040); use in epitope-based vaccines |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | US7026350 Water-soluble drugs and methods for their production |
| 04/11/2006 | US7026348 Antiinflammatory agents; sepsis shock; rheumatic diseases |
| 04/11/2006 | US7026347 Porphyrin-polyamine conjugates for cancer therapy |
| 04/11/2006 | US7026346 Anticancer agents |
| 04/11/2006 | US7026336 4-pyridinylimidazol-2-ylhydrocarbyl amine, (thio)urea, carbamic acid or sulfonamide derivatives, e.g., (2-(4-(4-Chloro-3-methoxy-phenyl)-5-pyridin-4-yl-1H-imidazol-2-yl)-2-methyl-propyl)-carbamic acid tert-butyl ester; Raf kinase inhibitors for the treatment of neurotraumatic diseases |
| 04/11/2006 | US7026335 Melanocortin receptor ligands |
| 04/11/2006 | US7026331 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 04/11/2006 | US7026326 Substituted heterocyclic compounds and methods of use |
| 04/11/2006 | US7026318 Compounds exhibiting X-type sPLA2 inhibiting effect |
| 04/11/2006 | US7026316 (optionally aza)cycloalkyl-N,N-optionally thia-, oxothia- or dioxothia-)alkyleneglycine derivatives, e.g., N-{4-[(1S)-1-amino-2-oxo-2-(1,3-thiazolidin-3-yl)ethyl]cyclohexyl}-N'-hexylureA; especially treating type 2 diabetes |
| 04/11/2006 | US7026313 2-thia-1,6,8-triaza-naphthalene-2,2-dioxides are kinase inhibitors |
| 04/11/2006 | US7026311 Dibenzodiazepine derivatives, their preparation and use |
| 04/11/2006 | US7026310 Heteroaryl derivatives and their use as medicaments |
| 04/11/2006 | US7026284 Formative agent of protein complex |
| 04/11/2006 | US7026281 Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
| 04/11/2006 | US7026270 malayamycin A and desmethylmalayamycin A prepared from a previously unknown strain of Streptomyces malaysiensis, used for combating or controlling phytopathogenic fungi |
| 04/11/2006 | US7026162 Expression vector for use as tool in genetic engineering |
| 04/11/2006 | US7026118 use of CaN subunit B for the manufacture of medicament for the treatment of mammalian cancer by regulating the immune system. |
| 04/11/2006 | US7026005 Dehydrating; steaming; drying; freezing; pulverization |
| 04/11/2006 | US7025993 Herbal composition PHY906 and its use in chemotherapy |
| 04/11/2006 | US7025988 Forming dehydration-rehydration vesicles with lipophilic drug paclitaxel, dissolving sugar into the aqueous suspension; drug delivery of antitumor treatment |
| 04/11/2006 | US7025987 Delivery system for nucleic acids |
| 04/11/2006 | CA2358829C Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/11/2006 | CA2199117C Compounds and methods for the treatment of cancer |
| 04/11/2006 | CA2157128C Camptothecin derivatives, preparations thereof and antitumor agents |
| 04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/11/2006 | CA2089440C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them |
| 04/11/2006 | CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 04/06/2006 | WO2008034796A2 Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors |
| 04/06/2006 | WO2006036981A2 Small molecule modulators of cytokine activity |
| 04/06/2006 | WO2006036269A2 Microspheres capable of binding radioisotopes, optionally comprising metallic microparticles, and methods of use thereof |
| 04/06/2006 | WO2006036131A1 A novel compound and a novel microorganism for producing the novel compound |
| 04/06/2006 | WO2006036031A1 Fused furan derivative and use thereof |
| 04/06/2006 | WO2006036024A1 Proton pump inhibitors |
| 04/06/2006 | WO2006036004A1 Telomelysin-gfp gene-containing recombinant virus |
| 04/06/2006 | WO2006035974A1 Oligoribonucleotide |
| 04/06/2006 | WO2006035954A1 Carbostyril compound |
| 04/06/2006 | WO2006035939A1 Immune stimulating oligonucleotide and use thereof in pharmaceutical |
| 04/06/2006 | WO2006035936A1 Par-2 antagonists |
| 04/06/2006 | WO2006035900A1 Coenzyme q10-containing emulsified composition |
| 04/06/2006 | WO2006035717A1 Antitumor composition |
| 04/06/2006 | WO2006035204A2 Combination comprising zd6474 and an imatinib |